World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
29247
World Ranking
18281
National Ranking
964

Overview

Marc Remke is affiliated with the German Cancer Research Center in Germany. Their research primarily focuses on the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Within these main fields, their work encompasses subfields such as Molecular Biology, Genetics, Cancer Research, Immunology, and Neurology.

Marc Remke's research covers several main topics, including:

  • Glioma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Cancer, Hypoxia, and Metabolism
  • Histone Deacetylase Inhibitors Research
  • Cancer-related molecular mechanisms research
  • Chromatin Remodeling and Cancer
  • Neuroblastoma Research and Treatments

The scientist has published numerous papers, with some recent notable works being:

  • "Germline Elongator mutations in Sonic Hedgehog medulloblastoma," 2020, Nature
  • "Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance," 2021, Journal of Clinical Oncology
  • "Involvement of CXCL1/CXCR2 During Microglia Activation Following Inflammation-Sensitized Hypoxic-Ischemic Brain Injury in Neonatal Rats," 2020, Frontiers in Neurology
  • "Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma," 2020, Neuro-Oncology
  • "Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression," 2021, ACS Central Science

Marc Remke frequently publishes in the following venues:

  • Neuro-Oncology
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuro-Oncology Advances
  • Cancer Research

The scientist collaborates regularly with several co-authors, including:

  • Daniel Picard
  • Nan Qin
  • Guido Reifenberger
  • Arndt Borkhardt
  • Stefan M. Pfister

Best Publications

  • Molecular Subgroups of Medulloblastoma: The Current Consensus

    Michael D. Taylor;Paul A. Northcott;Andrey Korshunov;Marc Remke;Marc Remke

  • Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock

  • Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

    Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones

  • Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

    Tobias Rausch;David T.W. Jones;Marc Zapatka;Adrian M. Stütz

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Paul A. Northcott;Catherine Lee;Catherine Lee;Thomas Zichner;Adrian M. Stütz

  • Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

    S. C. Mack;H. Witt;R. M. Piro;L. Gu

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

    Hendrik Witt;Stephen C. Mack;Marina Ryzhova;Sebastian Bender;Sebastian Bender

  • BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

    Stefan Pfister;Wibke G. Janzarik;Marc Remke;Aurélie Ernst

  • Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

    Nataliya Zhukova;Vijay Ramaswamy;Marc Remke;Elke Pfaff

  • Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

    Paul A. Northcott;David J H Shih;Marc Remke;Marc Remke;Yoon-Jae Cho

  • The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation

    Gabriel Leprivier;Marc Remke;Marc Remke;Barak Rotblat;Adrian Dubuc

  • Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Claudia C. Faria

  • Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

    Sharareh Gholamin;Sharareh Gholamin;Siddhartha S. Mitra;Abdullah H. Feroze;Jie Liu

  • Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers.

    Adam Shlien;Brittany B Campbell;Richard de Borja;Ludmil B Alexandrov

  • Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

    Stefan Pfister;Marc Remke;Axel Benner;Frank Mendrzyk

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Michael D. Taylor
Michael D. Taylor University of Toronto
Vijay Ramaswamy
Vijay Ramaswamy University of Toronto
Paul A. Northcott
Paul A. Northcott St. Jude Children's Research Hospital
Marcel Kool
Marcel Kool German Cancer Research Center
Peter Lichter
Peter Lichter German Cancer Research Center
David T. W. Jones
David T. W. Jones German Cancer Research Center
Andreas von Deimling
Andreas von Deimling Heidelberg University
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Uri Tabori
Uri Tabori University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of related online degrees and career pathways. For those eager to fast-track their entry into the healthcare field, there are absn programs that don't require teas, offering a streamlined admission process and less testing stress for nursing applicants.

Beyond direct patient care, healthcare management is a popular route, with plenty of accelerated healthcare administration degree options available online. These programs equip students for roles in hospital administration, policy management, or healthcare consulting—often in as little as 12-18 months.

Registered nurses aiming to advance their careers can benefit from flexible rn to np bridge program pathways, allowing them to earn a master’s degree without repeating foundational coursework. This is ideal for moving toward nurse practitioner or leadership positions.

For those interested in preventative health or wellness, the best online nutrition degree programs provide scientific knowledge applicable to dietetics, sports nutrition, and health education. With a variety of online choices, students can fit their studies around busy lives while preparing for vital roles in modern healthcare.

Best Scientists Citing Marc Remke

Trending Scientists